You are on page 1of 2

Federal Register / Vol. 72, No.

13 / Monday, January 22, 2007 / Notices 2707

Scientific Review, National Institutes of Place: Villa Florence Hotel, 225 Powell Time: 8 a.m. to 5 p.m.
Health, 6701 Rockledge Drive, Room 4218, Street, San Francisco, CA 94102. Agenda: To review and evaluate grant
MSC 7812, Bethesda, MD 20892, (301) 435– Contact Person: Dana Jeffrey Plude, PhD, applications.
2778, wangjia@csr.nih.gov. Scientific Review Administrator, Center for Place: Doubletree Hotel and Executive
Name of Committee: Immunology Scientific Review, National Institutes of Meeting Center, 8120 Wisconsin Avenue,
Integrated Review Group, Cellular and Health, 6701 Rockledge Drive, Room 3176, Bethesda, MD 20814.
Molecular Immunology—B Study Section. MSC 7848, Bethesda, MD 20892, 301–435– Contact Person: Anshumali Chaudhari,
Date: February 15–16, 2007. 2309, pluded@csr.nih.gov. PhD, Scientific Review Administrator, Center
Time: 8:30 a.m. to 5 p.m. Name of Committee: Center for Scientific for Scientific Review, National Institutes of
Agenda: To review and evaluate grant Review Special Emphasis Panel, Oncology Health, 6701 Rockledge Drive, Room 4124,
applications. Area. MSC 7802, Bethesda, MD 20892, (301) 435–
Place: Residence Inn Bethesda, 7335 Date: February 19, 2007. 1210, chaudhaa@csr.nih.gov.
Wisconsin Avenue, Bethesda, MD 20814. Time: 10 a.m. to 1 p.m. (Catalogue of Federal Domestic Assistance
Contact Person: Betty Hayden, PhD, Agenda: To review and evaluate grant Program Nos. 93.306, Comparative Medicine;
Scientific ReviewAdministrator, Center for applications. 93.333, Clinical Research, 93.306, 93.333,
Scientific Review, National Institutes of Place: National Institutes of Health, 6701 93.337, 93.393–93.396, 93.837–93.844,
Health, 6701 Rockledge Drive, Room 4206, Rockledge Drive, Bethesda, MD 20892, 93.846–93.878, 93.892, 93.893, National
MSC 7812, Bethesda, MD 20892, 301–435– (Virtual Meeting). Institutes of Health, HHS)
1223, haydenb@csr.nih.gov. Contact Person: Lambratu Rahman, PhD, Dated: January 12, 2007.
Name of Committee: Health of the Scientific Review Administrator, Center for
David Clary,
Population Integrated Review Group, Kidney, Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6214, Acting Director, Office of Federal Advisory
Nutrition, Obesity and Diabetes Study
MSC 7804, Bethesda, MD 20892, 301–451– Committee Policy.
Section.
Date: February 15–16, 2007. 3493, rahmanl@csr.nih.gov. [FR Doc. 07–241 Filed 1–19–07; 8:45 am]
Time: 8:30 a.m. to 5:30 p.m. Name of Committee: Infectious Diseases BILLING CODE 4140–01–M
Agenda: To review and evaluate grant and Microbiology Integrated Review Group,
applications. Bacterial Pathogenesis Study Section.
Place: Bethesda Marriott, 5151 Pooks Hill Date: February 20–21, 2007. DEPARTMENT OF HEALTH AND
Road, Bethesda, MD 20814. Time: 8 a.m. to 5 p.m. HUMAN SERVICES
Contact Person: Christopher T. Sempos, Agenda: To review and evaluate grant
PhD, Scientific Review Administrator, Center applications. National Institutes of Health
for Scientific Review, National Institutes of Place: The Watergate, 2650 Virginia
Health, 6701 Rockledge Drive, Room 3146 Avenue, NW., Washington, DC 20037. Prospective Grant of Exclusive
MSC 7770, Bethesda, MD 20892, (301) 451– Contact Person: Richard G. Kostriken, PhD, License: Devices for Countercurrent
1329, semposch@csr.nih.gov. Scientific Review Administrator, Center for Chromatography
Name of Committee: Center for Scientific Scientific Review, National Institutes of
Review Special Emphasis Panel, BTSS Health, 6701 Rockledge Drive, Room 3192, AGENCY: National Institutes of Health,
Member Conflict ZRG1 SBIB–E (03) M. MSC 7808, Bethesda, MD 20892, 301–402– Public Health Service, HHS.
Date: February 15, 2007. 4454, kostrikr@csr.nih.gov. ACTION: Notice.
Time: 1 p.m. to 2 p.m. Name of Committee: Center for Scientific
Agenda: To review and evaluate grant Review Special Emphasis Panel, Cancer SUMMARY: This is notice, in accordance
applications. Diagnostic and Treatment II, SBIR/STTR. with 35 U.S.C. 209(c)(1) and 37 CFR
Place: National Institutes of Health, 6701 Date: February 20–21, 2007. 404.7(a)(1)(i), that the National
Rockledge Drive, Bethesda, MD 20892, Time: 8 a.m. to 11:55 p.m. Institutes of Health (NIH), Department
(Telephone Conference Call). Agenda: To review and evaluate grant of Health and Human Services, is
Contact Person: Roberto J. Matus, MD, applications.
contemplating the grant of an exclusive
Scientific Review Administrator, Center for Place: National Institutes of Health, 6701
Scientific Review, National Institutes of Rockledge Drive, Bethesda, MD 20892, worldwide license to practice the
Health, 6701 Rockledge Drive, Room 5108, (Virtual Meeting). invention embodied in: HHS Ref. No. E–
MSC 7854, Bethesda, MD 20892, 301–435– Contact Person: Hungyi Shau, PhD, 274–1998 ‘‘Chromatographic Separation
2204, matusr@csr.nih.gov. Scientific Review Administrator, Center for Apparatus and Method,’’ U.S. Patent
Name of Committee: Center for Scientific Scientific Review, National Institutes of No. 6,379,973; HHS Ref. No. E–044–
Review Special Emphasis Panel, SRA Health, 6701 Rockledge Drive, Room 6214, 1993 ‘‘Variable-Position Cross-Axis
Conflict-Cardiovascular Differentiation and MSC 7804, Bethesda, MD 20892, 301–435– Synchronous Coil Plant Centrifuge for
Development. 1720, shauhung@csr.nih.gov. Countercurrent Chromatography;’’ U.S.
Date: February 16, 2007. Name of Committee: Center for Scientific Patent 5,380,429; HHS Ref. No. E–148–
Time: 10 a.m. to 11 a.m. Review Special Emphasis Panel, Cancer 2001 ‘‘Method and Apparatus for
Agenda: To review and evaluate grant Diagnostic and Treatment I, SBIR/STTR. Countercurrent Chromatography;’’ U.S.
applications. Date: February 20–21, 2007.
Place: Wyndham Washington, DC, 1400 M Time: 8 a.m. to 11:50 p.m.
Patent Application No. 10/509,697 filed
Street, NW., Washington, DC 20005. Agenda: To review and evaluate grant April 5, 2002; to CC Biotech LLC, a
Contact Person: Lawrence E. Boerboom, applications. company incorporated under the laws of
PhD, Scientific Review Administrator, Center Place: National Institutes of Health, 6701 the State of Maryland having its
for Scientific Review, National Institutes of Rockledge Drive, Bethesda, MD 20892, headquarters in Rockville, Maryland.
Health, 6701 Rockledge Drive, Room 5156, (Virtual Meeting). The United States of America is the
MSC 7814, Bethesda, MD 20892, (301) 435– Contact Person: Hungyi Shau, PhD, assignee of the rights of the above
8367, boerboom@nih.gov. Scientific Review Administrator, Center for inventions. The contemplated exclusive
Name of Committee: Center for Scientific Scientific Review, National Institutes of license may be granted in a field of use
Review Special Emphasis Panel, Small Health, 6701 Rockledge Drive, Room 6214,
limited to instrumentation for
rmajette on PROD1PC67 with NOTICES

Business: Psychopathology, Developmental MSC 7804, Bethesda, MD 20892, 301–435–


1720, shauhung@csr.nih.gov. countercurrent chromatographic
Disabilities and Disorders of Aging.
Date: February 19, 2007. Name of Committee: Cardiovascular
purification of proteins and peptides.
Time: 8 a.m. to 6 p.m. Sciences Integrated Review Group, Vascular DATES: Only written comments and/or
Agenda: To review and evaluate grant Cell and Molecular Biology Study Section. applications for a license received by
applications. Date: February 20–21, 2007. the NIH Office of Technology Transfer

VerDate Aug<31>2005 15:20 Jan 19, 2007 Jkt 211001 PO 00000 Frm 00061 Fmt 4703 Sfmt 4703 E:\FR\FM\22JAN1.SGM 22JAN1
2708 Federal Register / Vol. 72, No. 13 / Monday, January 22, 2007 / Notices

on or before March 23, 2007 will be arrangement allows for larger coils 1995. The information collection is
considered. which can hold between 200 ml and 800 published to obtain comments from the
ADDRESSES: Requests for a copy of the ml of sample. public and affected agencies. Comments
patent application, inquiries, comments are encouraged and will be accepted for
E–148–2001, ‘‘Method and Apparatus
and other materials relating to the sixty days until March 23, 2007.
for Countercurrent Chromatography,’’ Written comments and suggestions
contemplated license should be directed U.S. Patent Application No. 10/509,697
to: Michael A. Shmilovich, Esq., Office regarding the item(s) contained in this
(WIPO publication 03/087807) notice, and especially regarding the
of Technology Transfer, National
This device and method is an estimated public burden and associated
Institutes of Health, 6011 Executive
improvement of the countercurrent response time, should be directed to the
Boulevard, Suite 325, Rockville, MD
chromatography devices described Department of Homeland Security
20852–3804; Telephone: (301) 435–
above. This patent pending device is a (DHS), USCIS, Director, Regulatory
5019; Facsimile: (301) 402–0220; E-mail:
new spiral design capable of holding Management Division, Clearance
shmilovm@mail.nih.gov. A signed
heavier solvent systems suitable for Office,111 Massachusetts Avenue, NW.,
confidentiality nondisclosure agreement
peptides and proteins (e.g., for natural 3rd Floor, Suite 3008, Washington, DC
will be required to receive copies of any
products). 20529. Comments may also be
patent applications that have not been The prospective exclusive license will
published by the United States Patent submitted to DHS via facsimile to 202–
be royalty bearing and will comply with 272–8352, or via e-mail at
and Trademark Office or the World the terms and conditions of 35 U.S.C.
Intellectual Property Organization. rfs.regs@dhs.gov. When submitting
209 and 37 CFR 404.7. The prospective comments by e-mail add the OMB
SUPPLEMENTARY INFORMATION: The exclusive license may be granted unless, Control Number 1615–0059 in the
patents and patent applications within sixty (60) days from the date of subject box.
intended for licensure disclose or cover this published notice, NIH receives Written comments and suggestions
the following: written evidence and argument that from the public and affected agencies
E–274–1998, ‘‘Chromatographic establishes that the grant of the license concerning the collection of information
Separation Apparatus and Method,’’ would not be consistent with the should address one or more of the
U.S. Patent No. 6,379,973 requirements of 35 U.S.C. 209 and 37 following four points:
CFR 404.7. (1) Evaluate whether the collection of
This invention pertains to an Properly filed competing applications information is necessary for the proper
apparatus and method for separating for a license filed in response to this performance of the functions of the
bio-molecules using a salt (e.g., notice will be treated as objections to agency, including whether the
ammonium sulfate) gradient applied in the contemplated license. Comments information will have practical utility;
a spiral flow channel divided by a and objections submitted in response to (2) Evaluate the accuracy of the
dialysis membrane. The channels are this notice will not be made available agency’s estimate of the burden of the
compartmentalized into upper and for public inspection, and, to the extent collection of information, including the
lower rotary discs spinning anti- permitted by law, will not be released validity of the methodology and
clockwise to each other. Sample is under the Freedom of Information Act, assumptions used;
introduced in a buffered solution into 5 U.S.C. 552. (3) Enhance the quality, utility, and
the lower channel flows in one direction clarity of the information to be
Dated: January 12, 2007.
while the salt flows in the other. The collected; and
concentration of salt permeates the Steven M. Ferguson,
(4) Minimize the burden of the
membrane and precipitates the large Director, Division of Technology Development
collection of information on those who
molecules on the other side. For and Transfer, Office of Technology Transfer,
National Institutes of Health. are to respond, including through the
example, proteins or polymers are use of appropriate automated,
precipitates sequentially in the channel [FR Doc. 07–253 Filed 1–19–07; 8:45 am]
electronic, mechanical, or other
and centrifugal forces the precipitate to BILLING CODE 4140–01–M
technological collection techniques or
the outer rim as it moves along the other forms of information technology,
liquid stream. e.g., permitting electronic submission of
DEPARTMENT OF HOMELAND responses.
E–044–1993, ‘‘Variable-Position Cross- SECURITY
Axis Synchronous Coil Planet Overview of This Information
Centrifuge for Countercurrent U.S. Citizenship and Immigration Collection
Chromatography,’’ U.S. Patent No. Services
6,379,973 (1) Type of Information Collection:
Agency Information Collection Extension of a currently approved
This device is a cross-axis information collection.
synchronous flow-through coil planet Activities: Extension of a Currently
(2) Title of the Form/Collection:
centrifuge which provides changeability Approved Information Collection:
Application for Posthumous
in the position of the coils relative to the Comment Request
Citizenship.
axis of rotation of the centrifuge. The ACTION: 60-day notice of information (3) Agency form number, if any, and
advantage of this feature is to allow collection under review; application for the applicable component of the
adjustment of the centrifugal force posthumous citizenship; form N–644. Department of Homeland Security
operating on the coils to accommodate OMB control number 1615–0059. sponsoring the collection: Form N–644,
different types of separations. The coils U.S. Citizenship and Immigration
are arranged in columns which are The Department of Homeland Services.
rmajette on PROD1PC67 with NOTICES

mounted to column holders that in turn Security, U.S. Citizenship and (4) Affected public who will be asked
can be engaged to the rotary frame of the Immigration Services has submitted the or required to respond, as well as a brief
centrifuge in position in which the following information collection request abstract: Primary: Individual or
column holders intersect and do not for review and clearance in accordance households. The information collected
intersect the rotary frame axis. This with the Paperwork Reduction Act of will be used to determine an applicant’s

VerDate Aug<31>2005 15:20 Jan 19, 2007 Jkt 211001 PO 00000 Frm 00062 Fmt 4703 Sfmt 4703 E:\FR\FM\22JAN1.SGM 22JAN1